GlassScriptPhysician profile
Stanley H Schack
NPI 1750491692
$3,122.02
in general payments reported to CMS, 2019-2025
16 companies · $414 in 2025
The $414 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,057 · 2020: $564 · 2021: $419 · 2022: $214 · 2023: $116 · 2024: $339 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $1,039.13 | 2019-2021 | |
| Acclarent, INC | $489.85 | 2019-2023 | Relieva Tract |
| Aerin Medical INC. | $348.23 | 2019-2025 | |
| Optinose US, INC. | $304.81 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $226.43 | 2021-2024 | Dupixent |
| Genzyme Corporation | $189.11 | 2024-2025 | |
| Stryker Corporation | $124.32 | 2020-2022 | |
| Glaxosmithkline, LLC. | $96.21 | 2023-2025 | Nucala |
| Kaleo, INC. | $80.77 | 2021-2022 | |
| Itamar Medical INC | $54.97 | 2024 | Watchpatone |
| Amgen INC. | $45.20 | 2025 | Tezspire |
| Medtronic USA, INC. | $42.77 | 2019 | |
| Alk-Abello, INC | $29.49 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.36 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $14.01 | 2025 | Neffy |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Schack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.